A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
Clinical trial NCT05943795 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05943795
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2026-07-01
- Enrollment
- 589
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.